2nd Annual PK/PD of Novel Constructs 2013

Key Topics

• Using PKPD Modellingto Evaluate Novel Biologic Constructs
• Impact of Brentuximab Vedotin in the Treatmentof Lymphoma
• Considerations in the Development of Antibody-Maytansinoid Conjugates
• Quality Attributes That May Impact PK or Mechanism of Action
• Modeling & Simulation of Bispecific Antibodies in Oncology
• Properties of Fleximer™ to Improve Pharmacokinetics
• PK/PD Modeling to Determine Individual Dose Response
• Guiding ADC Development by Employing PK/PD Modeling and Simulation Approaches
• Engineering of pH-Dependent Binding Antibodies for Improved Pharmacokinetics
• PK Optimization of Bispecific DART Proteins for Clinical Use
• Antigen Sweeping Effect of Antibody with pH-Dependent Antigen Binding and Increased FcR Binding

Who should Attend

Senior executives and scientists from laboratories, Bio-research Centers, Pharmaceutical companies, universities, government and more.